Arvinas (ARVN) Total Debt Growth (3y) (2020 - 2026)
Arvinas (ARVN) Total Debt Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,192.35 Bn | 67,192.06 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | 50.25% |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.52 Bn | 466.73 Bn | 1.35 Bn | 25.25% |
| 5 | Vertex Pharmaceuticals | 121.73 Bn | 114.48 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.88 Bn | 61.13 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 63.11 Bn | 63.11 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.70 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Arvinas | 527.42 Mn | -87.48 Mn | - | -23.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.11% |
| Dec 31, 2025 | -26.32% |
| Sep 30, 2025 | -15.66% |
| Jun 30, 2025 | -11.21% |
| Mar 31, 2025 | -11.21% |
| Dec 31, 2024 | -7.17% |
| Sep 30, 2024 | -15.66% |
| Jun 30, 2024 | -11.21% |
| Mar 31, 2024 | -29.53% |
| Dec 31, 2023 | -26.32% |
| Sep 30, 2023 | -15.66% |
| Jun 30, 2023 | -20.63% |
| Mar 31, 2023 | -18.07% |
| Dec 31, 2022 | -20.63% |
| Sep 30, 2022 | -20.63% |
| Jun 30, 2022 | -21.55% |
| Mar 31, 2022 | -22.08% |
| Dec 31, 2021 | -22.57% |
| Sep 30, 2021 | -23.05% |
| Dec 31, 2020 | 86.08% |